Skip to main content
BGI Genomics Co., Ltd. logo

BGI Genomics Co., Ltd. — Investor Relations & Filings

Ticker · 300676 ISIN · CNE100003449 Shenzhen Stock Exchange Professional, scientific and technical activities
Filings indexed 1,656 across all filing types
Latest filing 2017-07-13 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300676

About BGI Genomics Co., Ltd.

https://www.bgi.com

BGI Genomics Co., Ltd. is a leading provider of integrated solutions for precision medicine, specializing in genomic sequencing and proteomic services. The company offers a comprehensive portfolio of clinical diagnostics and research services across various fields, including reproductive health, oncology, and infectious diseases. Key products include non-invasive prenatal testing, hereditary cancer screening, and pathogen identification tools. Leveraging proprietary DNBseq sequencing technology, BGI Genomics provides high-throughput, cost-effective genomic data analysis to healthcare providers, research institutions, and pharmaceutical companies worldwide. The organization focuses on advancing personalized medicine through large-scale genomic research and the development of innovative diagnostic applications, aiming to improve health outcomes by making advanced genetic insights accessible to a global population.

Recent filings

Filing Released Lang Actions
首次公开发行股票并在创业板上市之上市公告书更正公告
Regulatory Filings Classification · 95% confidence The document is a correction announcement related to a previously published IPO prospectus (首次公开发行股票并在创业板上市之上市公告书) for Shenzhen BGI Genomics Co., Ltd. It supplements financial data of the controlling shareholder that was omitted due to oversight. The document does not contain a full financial report but rather a correction and additional disclosure to an IPO announcement. It is short (1851 characters) and serves as an announcement correcting and supplementing previously disclosed information. Therefore, it fits best as a Regulatory Filing (RNS) rather than a full Annual Report, IPO prospectus, or other detailed report type.
2017-07-13 Chinese
首次公开发行股票并在创业板上市之上市公告书(更新后)
Regulatory Filings Classification · 95% confidence The document is a detailed announcement related to the initial public offering (IPO) and listing of Shenzhen BGI Genomics Co., Ltd. on the Shenzhen Stock Exchange's Growth Enterprise Market (创业板). It includes extensive disclosures about share lock-up commitments, stock price stabilization measures, compensation commitments, profit distribution policies, and other regulatory compliance information related to the IPO process. The document is titled as a "上市公告书" which translates to "Listing Announcement Document" or "IPO Listing Announcement." It is not a financial report like an Annual Report (10-K) or Interim Report (IR), nor is it a simple announcement of a report publication. It is also not a proxy statement, voting results, or management change announcement. The content focuses on the IPO listing, share lock-up, and related commitments, which fits best under the category of Regulatory Filings (RNS) as it is a regulatory disclosure document that does not fit other specific categories.
2017-07-13 Chinese
国浩律师(深圳)事务所关于公司申请首次公开发行股票并在深圳证券交易所创业板上市之法律意见书
Regulatory Filings
2017-07-12 Chinese
首次公开发行股票并在创业板上市之上市公告书(已取消)
Regulatory Filings
2017-07-12 Chinese
首次公开发行股票并在创业板上市上市公告书提示性公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the initial public offering (IPO) and listing of Shenzhen BGI Genomics Co., Ltd. on the Shenzhen Stock Exchange's ChiNext board. It includes details such as stock code, number of shares issued, and risk warnings related to the listing. The document does not contain financial statements or detailed financial analysis but serves as a formal notice of the stock listing event. It is not a full annual or interim report, nor a detailed investor presentation or proxy statement. Given the content and length (under 5,000 characters), this fits the category of a Regulatory Filing (RNS) as a general regulatory announcement about the IPO and listing.
2017-07-12 Chinese
中信证券股份有限公司关于公司首次公开发行股票并在创业板上市之上市保荐书
Regulatory Filings
2017-07-12 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.